Literature DB >> 2714582

Intestinal lymphangiectasia markedly improved with antiplasmin therapy.

K Mine1, S Matsubayashi, Y Nakai, T Nakagawa.   

Abstract

A 35-yr-old woman with intestinal lymphangiectasia was treated with trans-4-aminomethyl cyclohexane carboxylic acid. After 6 wk of antiplasmin therapy, her serum total protein increased to normal levels and 131I-polyvinyl pyrrolidone excretion was also normalized. With a daily administration of trans-4-aminomethyl cyclohexane carboxylic acid, the patient has manifested no symptoms for 8 yr up to the present. Throughout the clinical course, the values for euglobulin lysis time showed a close relationship to changes in serum total protein. It was then suggested that increased plasma fibrinolysis may enhance lymphatic permeability to plasma proteins. During this treatment, a decreased percentage of T lymphocytes became normalized together with serum immunoglobulin values. In addition, the therapy has resulted in the disappearance of duodenal lesions observed endoscopically.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2714582     DOI: 10.1016/0016-5085(89)90532-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

1.  Primary Intestinal Lymphangiectasia.

Authors:  Charles M. Bliss; Paul C. Schroy III
Journal:  Curr Treat Options Gastroenterol       Date:  2004-02

2.  Enteral nutrition as a primary therapy for intestinal lymphangiectasia: value of elemental diet and polymeric diet compared with total parenteral nutrition.

Authors:  Kunihiko Aoyagi; Mitsuo Iida; Takayuki Matsumoto; Shotaro Sakisaka
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

3.  Protein-losing enteropathy cured by resection of adenomatous goiter: report of a case.

Authors:  Jun Takada; Hiroshi Araki; Masaya Kubota; Takashi Ibuka; Makoto Shiraki; Masahito Shimizu; Hisataka Moriwaki
Journal:  Clin J Gastroenterol       Date:  2015-04-07

4.  Anaemia in Waldmann's disease: A rare presentation of a rare disease.

Authors:  Shahira A El-Etreby; Ahmed Y Altonbary; Mohamed El Sorogy; Wagdi Elkashef; Jehan A Mazroa; Monir H Bahgat
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

5.  Acute jejunal ileus in intestinal lymphangiectasia.

Authors:  R Lenzhofer; M Lindner; A Moser; J Berger; C Schuschnigg; J Thurner
Journal:  Clin Investig       Date:  1993-07

6.  Protein-Losing Enteropathy and Gastropathy.

Authors:  Brian R. Landzberg; Mark B. Pochapin
Journal:  Curr Treat Options Gastroenterol       Date:  2001-02

7.  A primary intestinal lymphangiectasia patient diagnosed by capsule endoscopy and confirmed at surgery: a case report.

Authors:  You-Hong Fang; Bing-Ling Zhang; Jia-Guo Wu; Chun-Xiao Chen
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

8.  Successful treatment of protein-losing enteropathy induced by intestinal lymphangiectasia in a liver cirrhosis patient with octreotide: a case report.

Authors:  Hang Lak Lee; Dong Soo Han; Jin Bae Kim; Yong Chul Jeon; Joo Hyun Sohn; Joon Soo Hahm
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

9.  Primary intestinal lymphangiectasia diagnosed by double-balloon enteroscopy and treated by medium-chain triglycerides: a case report.

Authors:  Yu Lai; Tao Yu; Xiao-Yu Qiao; Li-Na Zhao; Qi-Kui Chen
Journal:  J Med Case Rep       Date:  2013-01-14

Review 10.  Primary intestinal lymphangiectasia (Waldmann's disease).

Authors:  Stéphane Vignes; Jérôme Bellanger
Journal:  Orphanet J Rare Dis       Date:  2008-02-22       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.